Gene Therapy For Ocular Rare Disease Pipeline Insight Report 2024
April 25, 2024 04:06 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Global Allogeneic Cell Therapy Pipeline Report 2024: Clinical Progress, Treatment Efficacy, and Commercial Potential
April 23, 2024 09:53 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Allogeneic Cell Therapies - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering Allogeneic cell therapies represent...
Global Oncology Precision Medicine Market Trends and Forecasts Report 2024: A $364 Billion Industry by 2035 Amidst a Clinical Trials Boom with Over 6,500 Trials
April 23, 2024 04:37 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration,...
T Cell Therapy Pipeline Insight Report 2024
April 18, 2024 11:34 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "T cell therapy - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The report covers comprehensive insights of present...
Global Targeted Sequencing Industry Research 2023-2033: Burgeoning Opportunities Adoption in Targeted Therapeutics in Oncology and Use in Clinical Research and Trials for Better Disease Pathogenesis
April 17, 2024 04:33 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture,...
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
February 01, 2024 03:16 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Overview of SAb Biotherapeutics' Drug SAB-176: Phase IIb Trial Insights, SWOT Analysis, and Market Forecast to 2032
January 30, 2024 05:31 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "SAB-176 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a...
Gene Delivery Technologies Global Market Report 2024: Significant Growth Projected as Asia-Pacific Set to Surge - Long-term Forecasts to 2028 and 2033
January 25, 2024 09:38 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Gene Delivery Technologies Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global gene delivery...
Small Molecule Drug Discovery Global Market Report 2024: Patient-Centric Approaches and Artificial Intelligence Transforms Drug Discovery in Small Molecule Research - Forecasts to 2028 and 2033
January 24, 2024 07:36 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Drug Discovery Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The small molecule drug discovery...
Global Cell and Gene Therapy CDMO Market Analysis Report 2023: A $2.54 Billion Industry in 2022 Growing with a CAGR of 30.75% During 2024-2029
January 08, 2024 12:53 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast" report has...